In a report published by The Japanese Society of Hematology, all-trans retinoic acid (ATRA) introduction into anthracycline based chemo intervention reduced mortality in APL patients by downregulating annexin II [20]. This evidence concerns the gene ANXA2 and acute promyelocytic leukemia.